ARCUTIS BIOTHERAPEUTICS, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/188461c8-5d76-4516-8b62-f9d743d23bce/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-12.2M | 2025-01-01 – 2025-12-31 | evidence 0001787306-26-000018 |
| FY 2024 | $-128.4M | 2024-01-01 – 2024-12-31 | evidence 0001787306-25-000029 |
| FY 2023 | $-241.1M | 2023-01-01 – 2023-12-31 | evidence 0001787306-24-000031 |
| FY 2022 | $-301.6M | 2022-01-01 – 2022-12-31 | evidence 0001787306-23-000023 |
| FY 2021 | $-206.5M | 2021-01-01 – 2021-12-31 | evidence 0001787306-22-000009 |
| FY 2020 | $-136.6M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-002272 |
| FY 2019 | $-43.1M | 2019-01-01 – 2019-12-31 | evidence 0001628280-21-002272 |
| FY 2018 | $-19.7M | 2018-01-01 – 2018-12-31 | evidence 0001628280-21-002272 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARCUTIS BIOTHERAPEUTICS, INC. — all facts · Revenue · Net Income